3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
31.01%
Revenue growth similar to IXX.DE's 30.56%. Walter Schloss would see if both companies share industry tailwinds.
28.02%
Gross profit growth under 50% of IXX.DE's 111.60%. Michael Burry would be concerned about a severe competitive disadvantage.
569.92%
EBIT growth below 50% of IXX.DE's 1762.69%. Michael Burry would suspect deeper competitive or cost structure issues.
569.92%
Operating income growth under 50% of IXX.DE's 2108.98%. Michael Burry would be concerned about deeper cost or sales issues.
166.51%
Net income growth under 50% of IXX.DE's 2085.42%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y revenue/share CAGR while IXX.DE stands at 72.96%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while IXX.DE stands at 72.96%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while IXX.DE stands at 40.59%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y net income/share CAGR while IXX.DE is at 163.90%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-100.00%
Negative 5Y net income/share CAGR while IXX.DE is 163.90%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-100.00%
Negative 3Y CAGR while IXX.DE is 21.53%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-100.00%
Negative equity/share CAGR over 10 years while IXX.DE stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-100.00%
Negative 5Y equity/share growth while IXX.DE is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-100.00%
Negative 3Y equity/share growth while IXX.DE is at 30.71%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.19%
AR growth of 26.19% while IXX.DE is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
3.17%
Inventory shrinking or stable vs. IXX.DE's 12.03%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.20%
Positive asset growth while IXX.DE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
No Data
No Data available this quarter, please select a different quarter.
-6.24%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
18.76%
SG&A growth well above IXX.DE's 4.47%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.